CD79A and extranodal nasal NK/T cell lymphoma: Results from the remaining 46 anti-EBV IgG and six anti-EBV IgA antibodies that were nominally significantly elevated in NKTCL cases compared to controls (P < 0.05) are shown in Supplementary Table 1.